ClinicalTrials.Veeva

Menu

Multiple Sclerosis and Fatigue Assessment

A

Asli Demirtaş

Status

Enrolling

Conditions

Multiple Sclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT05820334
Gazi University (2023-157)

Details and patient eligibility

About

Fatigue in patients with Multiple Sclerosis (MS) is a problem that is seen without physical exertion and affects the majority of patients. In studies on fatigue in the literature, it has been seen that subjective methods are frequently used by using evaluation scales based on patient statements, but objective evaluation methods are not yet sufficient. This study was planned to compare the measurement results by evaluating fatigue subjectively, objectively and cognitively in MS patients.

Full description

Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating, autoimmune disease of the central nervous system. It is characterized by clinical symptoms arising from lesions in the brain, spinal cord or optic nerves. Although fatigue is one of the most common and most disabling problems of individuals with MS, it is not yet fully understood. This affects the treatment and disease process in MS. Despite studies to elucidate the pathogenic mechanisms of fatigue, available information is limited. Several factors contribute to the limited fatigue research, but the most important is that 'fatigue' is often not clearly defined or meaningful measures cannot be made in clinical/research settings. The first step in the evaluation of fatigue, which is a complex symptom, is to start with the identification and analysis of the factors that may cause fatigue, and to comprehensively question the factors that may be effective and the patient's history, and to evaluate the fatigue subjectively and objectively after the comprehensive patient history. The fatigue of patients diagnosed with MS will be evaluated subjectively, objectively and cognitively. Other information about the disease of the patients will be recorded. Subjective fatigue assessment methods, objective fatigue assessment methods and cognitive fatigue assessment methods will be applied.

Enrollment

54 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being between the ages of 18-65,
  • Having a definite diagnosis of Relapsing Remitting MS by a neurologist,
  • Expanded Disability Status Scale (EDSS) score between 1-5.5,
  • To be stable in medical treatment,
  • Being able to stand independently for at least 60 seconds without any assistive device,
  • It is to be above 24 points according to the Mini-Mental State Examination (MMSE) evaluation.

Exclusion criteria

  • Being diagnosed with MS for less than 1 year,
  • Having had an MS attack in the last 3 months,
  • Being illiterate or unable to communicate in Turkish,
  • Having an active infection,
  • Being pregnant,
  • Having an orthopedic problem or having a surgery that may affect the lower extremity,
  • Having an additional neurological or circulatory disease that may cause balance disorder, a problem affecting the vision or vestibular tract, or a diagnosis of orthopedic surgery, rheumatological disease,
  • To be included in the physiotherapy and rehabilitation program in the last 3 months.

Trial contacts and locations

1

Loading...

Central trial contact

Aslı ÇELİK, MSc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems